Page 17 - Molecular Templates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular templates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Templates Today - Breaking & Trending Today

FDA Partial Hold on Cancer Drug Adds to Molecular Templates' Growing List of Woes

The FDA has asked for more information about cardiac complications reported last year in a Phase 1 study for the Molecular Templates cancer drug, MT-0169. The partial clinical hold comes as the biotech works through a corporate restructuring as well as second Nasdaq de-listing notice. ....

United States , Roger Waltzman , Bristol Myers Squibb , Molecular Therapeutics , Texas Based Molecular Templates , Medical Officer Roger Waltzman , Bristol Myers , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Ealth And Wellness ,

FDA Places Partial Clinical Hold on Phase 1 Trial of MT-0169 in R/R Myeloma or Non-Hodgkin Lymphoma

The FDA has placed a partial clinical hold on a phase 1 trial investigating MT-0169 in patients with relapsed/refractory multiple myeloma or non-Hodgkin lymphoma. ....

Roger Waltzman , Molecular Templates Inc , Molecular Templates , Non Hodgkin Lymphoma , Multiple Myeloma , Hematologic Oncology ,

Biotech layoffs gather pace as industry downturn persists

BioPharma ....

United States , Stewart Lyman , David Woodhouse , Cambridge Biopartners , Pearl Freier , Silicon Valley Bank , Biopharma Dive , Fate Therapeutics , Molecular Templates , Sorrento Therapeutics , Pharma Dive , Nabriva Therapeutics , Finch Therapeutics , Lance Minor ,

Molecular Templates Announces Partial Clinical Hold for Phase 1 Study of MT-0169

08.04.2023 - Partial hold based on previously disclosed cardiac events at 50 mcg/kg cohort; FDA to review safety data in lower dose cohortsAUSTIN, Texas, April 07, 2023 (GLOBE NEWSWIRE) - Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or . Seite 1 ....

Roger Waltzman , Molecular Templates , Multiple Myeloma , Very Good Partial Response , Chief Medical Officer ,

Molecular Templates Announces Partial Clinical Hold for Phase 1 Study of MT-0169

Molecular Templates Announces Partial Clinical Hold for Phase 1 Study of MT-0169
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Roger Waltzman , Molecular Templates Inc , Drug Administration , Molecular Templates , Multiple Myeloma , Very Good Partial Response , Chief Medical Officer , Shiga Like Toxin , Private Securities Litigation Reform Act , Safe Harbor , Molecular Template , Grace Kimhead ,